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Does an initial HIV infection provide any degree of protection from subsequent HIV infections? We 
may now have evidence that it does. A recent study by postdoctoral fellow Dr.  Keshet Ronen in the 
laboratory of Dr. Julie Overbaugh in the Human Biology Division showed, for the first time, that the 
risk of acquiring a second HIV infection (superinfection) is lower than the risk of acquiring an initial 
HIV infection.  In this longitudinal study published in PLoS Pathogens, next-generation sequencing 
of plasma samples from women in a high-risk cohort in Kenya revealed that the risk of acquiring a 
second infection is approximately one-half that of acquiring an initial infection. 
Scientists from the Overbaugh Lab, in collaboration with Erick Matsen’s group in Public Health 
Sciences and researchers at the UW and in Kenya, utilized previously reported data on HIV 
superinfection and appended new data to increase overall sample size. The researchers analyzed 
high-throughput sequencing of three HIV genes (gag, pol and env) from patient samples obtained 
over the course of several years. Cases of superinfection were identified upon the appearance of a 
different HIV clade that was phylogenetically distinct from the initial HIV infection at a later time point. 
Of the 146 women in the cohort at risk of superinfection, 21 cases of superinfection were detected. 
When the incidences of initial infection and superinfection were calculated, a statistically significant 
difference was found (p=0.0019). The larger size, greater statistical power and more advanced 
methods of the current study compared to previous studies allowed the researchers to observe 
significant differences between the incidences of initial and superinfection for the first time. The 
researchers controlled for behavioral and clinical differences that might affect infection risk when 
making the comparison. Additionally, when the timing of superinfection events was analyzed, 
Ronen et al. found that the reduced risk of superinfection did not appear until after six months had 
elapsed since the initial infection. 
"These results suggest HIV infection provides some protection from subsequent infection, an effect 
which may be mediated by a protective immune response," explained Dr. Ronen. Researchers have 
long assumed that the immune response to HIV infection would likely provide some level of 
protection from subsequent infections. However, the mere existence of superinfection cases shows  
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that this supposed protection is not fully complete. Until this study, compiling sufficient data to 
provide significant evidence in support of or against the theory of a protective effect following initial 
infection has not been easy to come by. 
The results of this study suggest that an adaptive immune response triggered by an initial HIV 
infection provides at least partial protection from secondary infection; the risk of superinfection is 
highest in the first six months after initial infection, before a potential adaptive immune response has 
had time to fully mature. However, in contradiction to this theory, a majority of the cases of 
superinfection involved distinct viruses of the same subtype. If protection from superinfection were 
the result of an adaptive immune response, one would expect the cases of superinfection to have 
been from less closely related viruses. Another potential explanation is that protection arises from 
the normal depletion of HIV-susceptible cells during immune system deterioration caused by the 
initial infection. 
The positive news of this outcome is that these results will undoubtedly help us to better understand 
the immune response during HIV infection. Dr. Ronen is optimistic about the future of these studies. 
"Characterizing this immune response could inform vaccine design, so we are now exploring the 
response of singly infected and superinfected individuals to identify immune functions that correlate 
with superinfection susceptibility." 
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Image from the manuscript published in the open access journal 
PLoS Pathogens. 
Kaplan-Meier curve showing initial and superinfection events 
over time at risk. The risk of superinfection following an initial 
infection is less than the risk of initial infection. 
 
